Nu Skin Enterprises (NUS)
(Delayed Data from NYSE)
$9.60 USD
+0.15 (1.59%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $9.60 0.00 (0.00%) 6:08 PM ET
5-Strong Sell of 5 5
A Value B Growth C Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NUS 9.60 +0.15(1.59%)
Will NUS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NUS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NUS
Nu Skin (NUS) Trims FY24 View Despite Q2 Earnings Beat
Nu Skin Enterprises (NUS) Q2 Earnings and Revenues Surpass Estimates
NUS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Nu Skin (NUS) Set to Report Q2 Earnings: What to Expect?
Nu Skin (NUS) Navigates a Tough Landscape on Growth Strategies
Nu Skin (NUS) Troubled by Customer Acquisition Challenges
Other News for NUS
3 Stocks to Sell Now Before the Bear Market Hits
D.A. Davidson Sticks to Its Hold Rating for Nu Skin (NUS)
Nu Skin price target lowered by $1.50 at DA Davidson, here's why
Nu Skin price target lowered by $2.50 at Citi, here's why
Nu Skin: Q2 Earnings Snapshot